MetLife, Inc. (NYSE:MET) Given Consensus Recommendation of “Moderate Buy” by Analysts

MetLife, Inc. (NYSE:MET) has been assigned a consensus recommendation of “Moderate Buy” from the thirteen analysts that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $90.46.

Several equities analysts recently commented on the stock. JPMorgan Chase & Co. boosted their price objective on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. TD Cowen boosted their price target on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research report on Wednesday, November 27th. Wells Fargo & Company lowered their price objective on MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 14th. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Finally, Piper Sandler lifted their price target on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd.

MetLife Stock Up 1.1 %

Shares of NYSE MET opened at $86.97 on Tuesday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The company has a market cap of $60.22 billion, a P/E ratio of 17.53, a P/E/G ratio of 0.65 and a beta of 1.07. MetLife has a 52 week low of $64.61 and a 52 week high of $89.05. The business has a 50-day simple moving average of $83.81 and a two-hundred day simple moving average of $80.11.

MetLife Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be given a dividend of $0.545 per share. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 annualized dividend and a yield of 2.51%. MetLife’s payout ratio is 43.95%.

Institutional Investors Weigh In On MetLife

A number of hedge funds and other institutional investors have recently modified their holdings of MET. MeadowBrook Investment Advisors LLC increased its stake in MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 220 shares during the period. Carmichael Hill & Associates Inc. raised its holdings in MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after buying an additional 186 shares during the last quarter. Wolff Wiese Magana LLC boosted its position in MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after buying an additional 277 shares during the period. Peterson Financial Group Inc. bought a new stake in MetLife in the 3rd quarter worth $30,000. Finally, Retirement Wealth Solutions LLC purchased a new position in shares of MetLife in the fourth quarter valued at about $32,000. Institutional investors own 94.99% of the company’s stock.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.